June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Inflammasomes in human eyes with AMD and mouse retinas with focal retinal degeneration
Author Affiliations & Notes
  • Chi-Chao Chan
    Immunopath Sect, Lab of Immunol, National Eye Institute/NIH, Bethesda, MD
  • DeFen Shen
    Immunopath Sect, Lab of Immunol, National Eye Institute/NIH, Bethesda, MD
  • Yujuan Wang
    Immunopath Sect, Lab of Immunol, National Eye Institute/NIH, Bethesda, MD
    Zhongshan Ophthalmic Center, Guangzhou, China
  • Xi Chu
    Immunopath Sect, Lab of Immunol, National Eye Institute/NIH, Bethesda, MD
  • Mones Abu-Asab
    Immunopath Sect, Lab of Immunol, National Eye Institute/NIH, Bethesda, MD
  • Jingsheng Tuo
    Immunopath Sect, Lab of Immunol, National Eye Institute/NIH, Bethesda, MD
  • Footnotes
    Commercial Relationships Chi-Chao Chan, None; DeFen Shen, None; Yujuan Wang, None; Xi Chu, None; Mones Abu-Asab, None; Jingsheng Tuo, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 315. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chi-Chao Chan, DeFen Shen, Yujuan Wang, Xi Chu, Mones Abu-Asab, Jingsheng Tuo; Inflammasomes in human eyes with AMD and mouse retinas with focal retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2013;54(15):315.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Inflammasome, a component of innate immune system, is multiprotein oligomers consisting of caspase 1, PYCARD and NLRP. Inflammasomes recognize the inflammatory induced stimuli including pathogen-associated molecular patterns (PAMPs) that are predominantly found in microbes, and damage-associated molecular patterns (DAMPs) that are released due to perturbation of tissue homeostasis. Inflammasomes typically activate IL-1β and IL-18. Recently, the role of inflammasomes has expanded from infection and inflammation to diabetes, obesity, artherosclerosis and age-related macular degeneration. In this study, we evaluated the expression of NLRP3 and IL-18 in the retinas of age-related macular degeneration (AMD) patients and Ccl2-/-/Cx3cr1-/- on rd8 background (DKO rd8), a model that develops progressive AMD-like retinal lesions including focal retinal degeneration, A2E accumulation and immune dysregulation, in addition to retinal dystrophy.

 
Methods
 

The macular and the peripheral retina and choroid of 16 paraffin-embedded, archived human AMD eyes (8 geographic atrophy (GA) and 7 neovascular (n) AMD) and 3 age-matched normal eyes were microdissected. Their RNA was isolated (Paradise RNA isolation system) for cDNA synthesis (SuperScript II RT system). The DKO rd8 and C57BL/6N mouse eyes, of ages 1, 5 and 12 months old were collected and their RNA was isolated with Trizol for cDNA synthesis. NLRP3 and IL-18 mRNA were quantitated by real time PCR monitored with SYBR Green fluorescence.

 
Results
 

The relative expression of transcript levels of NLRP3 (AMD, 161.4±83.6; normal, undetectable; p<0.0001) and IL-18 (AMD, 210.5±35.9, GA AMD, 242.7±46.0, nAMD, 173.6±56.1; normal, undetectable; p<0.0001) were found significantly higher in AMD lesions compared to the normal macula. Expression of both NLRP3 and IL-18 in the periphery was barely detected or below detectable levels in both AMD and normal peripheries. In the mice, both Nlrp3 and Il-18 transcripts elevated with age. The relative expression of Nlrp3 and Il-18 transcripts were also significantly higher in DKO rd8 eyes compared with that in C57BL/6N eyes throughout changes in aging.

 
Conclusions
 

Higher levels of inflammasome and related cytokine are expressed in human AMD macula and DKO rd8 mouse eyes compared to the controls. These findings support the aforementioned hypothesis that the innate immune system may play a role in AMD pathogenesis.

 
Keywords: 557 inflammation • 638 pathology: human • 413 aging  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×